Prostatic Neoplasms Recruiting Phase 2 Trials for Pembrolizumab (DB09037)
Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm
Indication | Status | Phase |
---|---|---|
DBCOND0028225 (Prostatic Neoplasms) | Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT03007732 | Pembrolizumab in Combination With Intratumoral SD-101 Therapy | Treatment |